Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TADORE-Plus: Tafenoquine and ACTs in Vivax Malaria
NCT07060794Phase 4Not yet recruiting
- Sponsor
- Menzies School of Health Research
- Start
- Jun 2026
- Primary completion
- Jun 2028
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
A Phase 4 trial of tafenoquine in vivax malaria, sponsored by Menzies School of Health Research. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
tafenoquine
03
Conditions
vivax malaria
Beyond the preview
Go deeper on NCT07060794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07060794.